Mylène Perreault

2.9k total citations · 1 hit paper
33 papers, 2.2k citations indexed

About

Mylène Perreault is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Mylène Perreault has authored 33 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Physiology and 5 papers in Epidemiology. Recurrent topics in Mylène Perreault's work include Adipose Tissue and Metabolism (10 papers), Nitric Oxide and Endothelin Effects (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Mylène Perreault is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Nitric Oxide and Endothelin Effects (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Mylène Perreault collaborates with scholars based in United States, Canada and France. Mylène Perreault's co-authors include André Marette, Denis Roy, James F. Tobin, Ruth E. Gimeno, Sonia Kapur, Frédéric Tremblay, Vipin Suri, Sarah Will, Caroline Kurtz and Vincent M. Isabella and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Gastroenterology.

In The Last Decade

Mylène Perreault

32 papers receiving 2.2k citations

Hit Papers

An engineered E. coli Nissle improves hyperammonemia and ... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers

Mylène Perreault
Ryan P. McMillan United States
Phillip J. White United States
Pengxiang She United States
Paul W. Hake United States
Peter Y. Wielinga Netherlands
Ryan P. McMillan United States
Mylène Perreault
Citations per year, relative to Mylène Perreault Mylène Perreault (= 1×) peers Ryan P. McMillan

Countries citing papers authored by Mylène Perreault

Since Specialization
Citations

This map shows the geographic impact of Mylène Perreault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mylène Perreault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mylène Perreault more than expected).

Fields of papers citing papers by Mylène Perreault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mylène Perreault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mylène Perreault. The network helps show where Mylène Perreault may publish in the future.

Co-authorship network of co-authors of Mylène Perreault

This figure shows the co-authorship network connecting the top 25 collaborators of Mylène Perreault. A scholar is included among the top collaborators of Mylène Perreault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mylène Perreault. Mylène Perreault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perreault, Mylène, Michael J. James, Sean L. Cotton, et al.. (2024). The live biotherapeutic SYNB1353 decreases plasma methionine via directed degradation in animal models and healthy volunteers. Cell Host & Microbe. 32(3). 382–395.e10. 23 indexed citations
2.
Zeng, Su-Ling, Yanhan Wang, Yi Duan, et al.. (2023). Engineered bacteria producing aryl‐hydrocarbon receptor agonists protect against ethanol‐induced liver disease in mice. Alcohol Clinical and Experimental Research. 47(5). 856–867. 27 indexed citations
3.
Lubkowicz, David, Michael J. James, Ron B. Shmueli, et al.. (2022). An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria. Molecular Systems Biology. 18(3). e10539–e10539. 35 indexed citations
4.
Lubkowicz, David, Michael J. James, Mark R. Charbonneau, et al.. (2020). Development of a Synthetic Biotic, SYNB8802, for the Treatment of Enteric Hyperoxaluria. Journal of the American Society of Nephrology. 31(10S). 245–245.
5.
Kurtz, Caroline, Yves Millet, Marja Puurunen, et al.. (2019). An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Science Translational Medicine. 11(475). 280 indexed citations breakdown →
6.
Perreault, Mylène, Feng Guo, Sarah Will, et al.. (2013). Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates. PLoS ONE. 8(5). e62616–e62616. 21 indexed citations
7.
Vugmeyster, Yulia, et al.. (2013). Agonistic TAM-163 antibody targeting tyrosine kinase receptor-B. mAbs. 5(3). 373–383. 16 indexed citations
8.
Trottier, J., Mylène Perreault, Iwona Rudkowska, et al.. (2013). Profiling Serum Bile Acid Glucuronides in Humans: Gender Divergences, Genetic Determinants, and Response to Fenofibrate. Clinical Pharmacology & Therapeutics. 94(4). 533–543. 42 indexed citations
9.
Cao, Jingsong, Yingjiang Zhou, Xinyi Huang, et al.. (2011). Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases. Journal of Biological Chemistry. 286(48). 41838–41851. 119 indexed citations
10.
Pilon, Geneviève, Alexandre Charbonneau, Phillip J. White, et al.. (2010). Endotoxin Mediated-iNOS Induction Causes Insulin Resistance via ONOO− Induced Tyrosine Nitration of IRS-1 in Skeletal Muscle. PLoS ONE. 5(12). e15912–e15912. 59 indexed citations
11.
Perreault, Mylène, Sarah Will, Kimberly Harding, et al.. (2009). Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice. Diabetes Obesity and Metabolism. 12(3). 234–245. 10 indexed citations
12.
Perreault, Mylène, David V. Erbe, & James F. Tobin. (2008). PPARδ Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities. PPAR Research. 2008(1). 125387–125387. 6 indexed citations
13.
Erbe, David V., Yanling Zhang, Vipin Suri, et al.. (2006). Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists. Vascular Pharmacology. 45(3). 154–162. 122 indexed citations
14.
Dubois, Marie-Julie, Sébastien Bergeron, Hyo‐Jeong Kim, et al.. (2006). The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nature Medicine. 12(5). 549–556. 119 indexed citations
15.
Tremblay, Frédéric, Mylène Perreault, Lori D. Klaman, et al.. (2006). Normal Food Intake and Body Weight in Mice Lacking the G Protein-Coupled Receptor GPR39. Endocrinology. 148(2). 501–506. 121 indexed citations
16.
Perreault, Mylène, et al.. (2004). Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. International Journal of Obesity. 28(7). 879–885. 102 indexed citations
17.
Perreault, Mylène & André Marette. (2001). Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nature Medicine. 7(10). 1138–1143. 426 indexed citations
18.
Picard, Frédéric, Sonia Kapur, Mylène Perreault, André Marette, & Yves Deshaies. (2001). Nitric oxide mediates endotoxin‐induced hypertriglyceridemia through its action on skeletal muscle lipoprotein lipase. The FASEB Journal. 15(10). 1828–1830. 29 indexed citations
19.
Perreault, Mylène, Luce Dombrowski, & André Marette. (2000). Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats. Diabetologia. 43(4). 427–437. 36 indexed citations
20.
Kapur, Sonia, Frédéric Picard, Mylène Perreault, Yves Deshaies, & André Marette. (2000). Nitric oxide: a new player in the modulation of energy metabolism. International Journal of Obesity. 24(S4). S36–S40. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026